Walker C, Joyce K A, Thompson-Hehir J, Davies M P, Gibbs F E, Halliwell N, Lloyd B H, Machell Y, Roebuck M M, Salisbury J, Sibson D R, Du Plessis D, Broome J, Rossi M L
Clatterbridge Cancer Research Trust, J.K. Douglas Laboratories, Clatterbridge Hospital, Bebington, Wirral CH63 4JY, UK.
Acta Neuropathol. 2001 Apr;101(4):321-33. doi: 10.1007/s004010000259.
Classification of gliomas according to their molecular characteristics may be important in future histopathological diagnosis. However, gliomas frequently display heterogeneity at the histological, biological and molecular level. In this study of archival diagnostic gliomas, precision microdissection was used to enrich samples in the most malignant cells or to investigate intratumoural histological heterogeneity. Analysis of tumour samples microdissected from the most aggressive regions, representative of the histopathological diagnosis, revealed PTEN mutations in 4/14 anaplastic astrocytomas, 4/13 glioblastomas and 1 gliosarcoma, but not in 19 low-grade gliomas. Using a novel PCR procedure and direct sequence analysis of the entire coding sequence, TP53 mutations were detected in 1/3 pilocytic astrocytomas, 3/13 astrocytomas, 4/14 anaplastic astrocytomas, 5/13 glioblastomas and 1 gliosarcoma. All but one of the tumours with TP53 mutation showed p53 immunopositivity, but 5 low-grade and 10 high-grade gliomas had p53 protein nuclear accumulation in the absence of detectable mutation. p53 status was unrelated to p21 expression. Neither PTEN nor TP53 mutations influenced the proliferative index or microvessel density of high-grade astrocytomas. Unusual findings include: TP53 mutation in a juvenile pilocytic astrocytoma; TP53 and PTEN mutations in a de novo glioblastoma, a gliosarcoma with identical mutations in gliomatous and sarcomatous components, and an infratentorial anaplastic astrocytoma with an earlier supratentorial grade II astrocytoma bearing the same TP53 mutation but not the PTEN mutation or loss of heterozygosity (LOH) of 10q23. Similarly, the transition to high-grade histology was associated with acquisition of PTEN mutations and 10q23.3 LOH in two de novo high-grade tumours with regions of low-grade histology.
根据分子特征对胶质瘤进行分类在未来的组织病理学诊断中可能很重要。然而,胶质瘤在组织学、生物学和分子水平上常常表现出异质性。在这项对存档诊断性胶质瘤的研究中,采用精确显微切割技术来富集最恶性细胞中的样本或研究肿瘤内的组织学异质性。对从最具侵袭性区域显微切割得到的肿瘤样本进行分析,这些区域代表了组织病理学诊断结果,结果显示在4/14例间变性星形细胞瘤、4/13例胶质母细胞瘤和1例胶质肉瘤中检测到PTEN突变,但在19例低级别胶质瘤中未检测到。使用一种新型PCR程序并对整个编码序列进行直接测序分析,在1/3例毛细胞型星形细胞瘤、3/13例星形细胞瘤、4/14例间变性星形细胞瘤、5/13例胶质母细胞瘤和1例胶质肉瘤中检测到TP53突变。除1例肿瘤外,所有TP53突变的肿瘤均显示p53免疫阳性,但5例低级别和10例高级别胶质瘤在未检测到突变的情况下出现p53蛋白核积聚。p53状态与p21表达无关。PTEN和TP53突变均未影响高级别星形细胞瘤的增殖指数或微血管密度。不寻常的发现包括:1例青少年毛细胞型星形细胞瘤中存在TP53突变;1例新发胶质母细胞瘤中存在TP53和PTEN突变,1例胶质肉瘤在胶质瘤成分和肉瘤成分中具有相同突变,1例幕下间变性星形细胞瘤之前有幕上II级星形细胞瘤,二者具有相同的TP53突变,但不存在PTEN突变或10q23杂合性缺失(LOH)。同样,在2例具有低级别组织学区域的新发高级别肿瘤中,向高级别组织学的转变与PTEN突变的获得和10q23.3 LOH相关。